The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Tyrosine Kinase Inhibition: An Approach to Drug Development
Abstract
Protein tyrosine kinases (PTKs) regulate cell proliferation, cell differentiation, and signaling processes in the cells of the immune system. Uncontrolled signaling from receptor tyrosine kinases and intracellular tyrosine kinases can lead to inflammatory responses and to diseases such as cancer, atherosclerosis, and psoriasis. Thus, inhibitors that block the activity of tyrosine kinases and the signaling pathways they activate may provide a useful basis for drug development. This article summarizes recent progress in the development of PTK inhibitors and demonstrates their potential use in the treatment of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Buchdunger, E., Trinks, U. P., Mett, H., Regenass, U., Müller, M., Meyer, T., McGlynn, E., Pinna, L. A., Traxler, P. M., & Lydon, N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2334 · Cited by 97
RetractedThe pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90667-f · Cited by 1,327
Identification of a Ten-Amino Acid Proline-Rich SH3 Binding Site
Ren, R., Mayer, B. J., Cicchetti, P., & Baltimore, D. (1993) · Science · doi:10.1126/science.8438166 · Cited by 1,191
Crystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080
Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
PLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 940
Grossman, R. M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D. P., May, L. T., Kupper, T. S., Sehgal, P. B., & Gottlieb, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6367 · Cited by 853
TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION: A COMMON MEDIATOR
Beutler, B., & Cerami, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002445 · Cited by 813
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Margolis, B., Rhee, S. G., Felder, S., Mervic, M., Lyall, R., Levitzki, A., Ullrich, A., Zilberstein, A., & Schlessinger, J. (1989) · Cell · doi:10.1016/0092-8674(89)90047-0 · Cited by 753
Self-citationWaksman, G. (1993) · Cell · doi:10.1016/0092-8674(93)90405-f · Cited by 735
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells
James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D., & Marsters, J. C. (1993) · Science · doi:10.1126/science.8316834 · Cited by 630
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
Gazit, A., Yaish, P., Gilon, C., & Levitzki, A. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00130a020 · Cited by 600
Self-citationBlocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors
Yaish, P., Gazit, A., Gilon, C., & Levitzki, A. (1988) · Science · doi:10.1126/science.3263702 · Cited by 587
Self-citationSelective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor
Kohl, N. E., Mosser, S. D., deSolms, S. J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, E. M., Oliff, A., & Gibbs, J. B. (1993) · Science · doi:10.1126/science.8316833 · Cited by 579
Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H.-K., Brady, J. N., & Gallo, R. C. (1994) · Nature · doi:10.1038/371674a0 · Cited by 570
Overexpression of Transforming Growth Factor α in Psoriatic Epidermis
Elder, J. T., Fisher, G. J., Lindquist, P. B., Bennett, G. L., Pittelkow, M. R., Coffey, R. J., Ellingsworth, L., Derynck, R., & Voorhees, J. J. (1989) · Science · doi:10.1126/science.2916128 · Cited by 527
Raetz, C. R. H., Ulevitch, R. I., Wright, S. D., Sibley, C. H., Ding, A., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.12.1916089 · Cited by 507
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Taylor, S. I. (1992) · Diabetes · doi:10.2337/diab.41.11.1473 · Cited by 344
Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors
Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N., & Levitzki, A. (1994) · Science · doi:10.1126/science.8191285 · Cited by 336
Self-citationLevitzki, A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.14.1426765 · Cited by 317
Self-citationBacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages.
Weinstein, S. L., Gold, M. R., & DeFranco, A. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4148 · Cited by 311
The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions.
Volberg, T., Zick, Y., Dror, R., Sabanay, I., Gilon, C., Levitzki, A., & Geiger, B. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05225.x · Cited by 310
Self-citationLipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn.
Stefanová, I., Corcoran, M. L., Horak, E. M., Wahl, L. M., Bolen, J. B., & Horak, I. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36840-1 · Cited by 298
Suramin: With Special Reference to Onchocerciasis
Hawking, F. (1978) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60486-x · Cited by 284
Epidermal‐Growth‐Factor‐Dependent Activation of the Src‐Family Kinases
Osherov, N., & Levitzki, A. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1047b.x · Cited by 281
Self-citationLyall, R. M., Zilberstein, A., Gazit, A., Gilon, C., Levitzki, A., & Schlessinger, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71707-9 · Cited by 278
Self-citationSelective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko, M. V., Gazit, A., Böhmer, A., Rorsman, C., Rönnstrand, L., Heldin, C., Waltenberger, J. L., Böhmer, F., & Levitzki, A. (1994) · PubMed · Cited by 269
Self-citationBetsholtz, C., Johnsson, A., Heldin, C. H., & Westermark, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6440 · Cited by 264
Epidermal growth factor receptor tyrosine kinase
Ward, W. H. J., Cook, P. N., Slater, A. M., Davies, D. H., Holdgate, G. A., & Green, L. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90042-6 · Cited by 261
Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gilon, C., & Levitzki, A. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00110a022 · Cited by 259
Self-citationMyers, C., Cooper, M., Stein, C., LaRocca, R., Walther, M. M., Weiss, G., Choyke, P., Dawson, N., Steinberg, S., & Uhrich, M. M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.881 · Cited by 233
Uehara, Y., Fukazawa, H., Murakami, Y., & Mizuno, S. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92293-6 · Cited by 211
Noble, M., Musacchio, A., Saraste, M., & Wierenga, R. (1993) · Worldwide Protein Data Bank · doi:10.2210/pdb1shf/pdb · Cited by 206
Geahlen, R. L., & McLaughlin, J. L. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91060-7 · Cited by 202
Noble, M. E., Musacchio, A., Saraste, M., Courtneidge, S. A., & Wierenga, R. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05922.x · Cited by 200
Signal-Transduction Therapy. A Novel Approach to Disease Management
Levitzki, A. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.000t1.x · Cited by 197
Self-citationSelective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins
Osherov, N., Gazit, A., Gilon, C., & Levitzki, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82102-0 · Cited by 195
Self-citationBooker, G. W., Gout, I., Kristina^Downing, A., Driscoll, P. C., Boyd, J., Waterfield, M. D., & Campbell, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)90259-s · Cited by 186
Signal-Transduction Therapy. A Novel Approach to Disease Management
Levitzki, A. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb20020.x · Cited by 184
Self-citationGRAZIANI, Y., ERIKSON, E., & ERIKSON, R. L. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07692.x · Cited by 178
Weinstein, S. L., June, C. H., & DeFranco, A. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3829 · Cited by 168
Dong, Z., Qi, X., Xie, K., & Fidler, I. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2717 · Cited by 161
Guy, G. R., Chua, S. P., Wong, N. S., Ng, S. B., & Tan, Y. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98690-4 · Cited by 158
Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogs
Cushman, M., Nagarathnam, D., Burg, D. L., & Geahlen, R. L. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00106a047 · Cited by 151
Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
Anafi, M., Gazit, A., Zehavi, A., Ben‐Neriah, Y., & Levitzki, A. (1993) · Blood · doi:10.1182/blood.v82.12.3524.3524 · Cited by 133
Self-citationDong, Z., Qi, X., & Fidler, I. J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.1071 · Cited by 132
Krane, J. F., Murphy, D. P., Carter, D. M., & Krueger, J. G. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469799 · Cited by 117
The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor
Ohmichi, M., Pang, L., Ribon, V., Gazit, A., Levitzki, A., & Saltiel, A. R. (1993) · Biochemistry · doi:10.1021/bi00068a024 · Cited by 113
Self-citationYoneda, T., Lyall, R. M., Alsina, M. M., Persons, P. E., Spada, A. P., Levitzki, A., Zilberstein, A., & Mundy, G. R. (1991) · PubMed · Cited by 112
Self-citationSolution structure of the SH3 domain of phospholipase C-?
Kohda, D. (1993) · Cell · doi:10.1016/0092-8674(93)90583-c · Cited by 111
Saperstein, R., Vicario, P. P., Strout, H. V., Brady, E. J., Slater, E. E., Greenlee, W. J., Ondeyka, D. L., Patchett, A. A., & Hangauer, D. G. (1989) · Biochemistry · doi:10.1021/bi00439a053 · Cited by 106
Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy, K. B., Mangold, G. L., Tandon, A. K., Yoneda, T., Mundy, G. R., Zilberstein, A., & Osborne, C. K. (1992) · PubMed · Cited by 105
Bacus, S. S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., & Yarden, Y. (1992) · PubMed · Cited by 101
Anafi, M., Gazit, A., Gilon, C., Ben‐Neriah, Y., & Levitzki, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42864-5 · Cited by 93
Self-citationTrinks, U. P., Buchdunger, E., Furet, P., Kump, W. G., Mett, H., Meyer, T., Mueller, M., Regenass, U., & RIHS, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00033a019 · Cited by 91
src-related protein tyrosine kinases and their surface receptors
Rudd, C. E., Janßen, O., Prasad, K. V. S., Raab, M., da Silva, A., Telfer, J. C., & Yamamoto, M. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90007-y · Cited by 82
Kaur, G., Gazit, A., Levitzki, A., Stowe, E., Cooney, D. A., & Sausville, E. A. (1994) · PubMed · Cited by 80
Self-citationDong, Z., O’Brian, C. A., & Fidler, I. J. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.53.1.53 · Cited by 79
Tyrphostin induced growth inhibition
Kaur, G., Gazit, A., Levitzki, A., Stowe, E., Cooney, D. A., & Sausville, E. A. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199404000-00013 · Cited by 78
Self-citationTyrosine phosphorylation is an obligatory event in IL-2 secretion.
Stanley, J., Gorczynski, R. M., Huang, C., Love, J., & Mills, G. B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.7.2189 · Cited by 73
Regulation of protein kinases activity by quercetin in Ehrlich ascites tumor cells
Graziani, Y., Chayoth, R., Karny, N., Feldman, B., & LEVY, J. (1982) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(82)90148-9 · Cited by 72
Herbimycin A blocks IL‐1‐induced NF‐κB DNA‐binding activity in lymphoid cell lines
Iwasaki, T., Uehara, Y., Graves, L. M., Rachie, N. A., & Bomsztyk, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80067-q · Cited by 69
Dukes, M., Miller, D., Wakeling, A. E., & Waterton, J. C. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1350239 · Cited by 61
Traxler, P. M., Wacker, O., Bach, H., Geissler, J. F., Kump, W. G., Meyer, T., Regenass, U., Roesel, J. L., & Lydon, N. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00112a003 · Cited by 57
Motzer, R. J., Nanus, D. M., O’Moore, P. V., Scher, H. I., Bajorin, D. F., Reuter, V. E., Tong, W. P., Iversen, J., Louison, C., & Albino, A. P. (1992) · PubMed · Cited by 50
Schneider, H., Cohen-Dayag, A., & Pecht, I. (1992) · International Immunology · doi:10.1093/intimm/4.4.447 · Cited by 49
CD26 induces T-cell proliferation by tyrosine protein phosphorylation.
Muñóz, E., Blazquez, M. V., Madueño, J. A., Rubio, G., & Peña, J. (1992) · PubMed · Cited by 45
Role of Tyrosine Kinases in IgE-mediated Signal Transduction in Human Lung Mast Cells and Basophils
Lavens, S. E., Peachell, P. T., & Warner, J. A. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.6.637 · Cited by 33
Biochemistry of the Src Protein-Tyrosine Kinase: Regulation by SH2 and SH3 Domains
Liu, X. J., & Pawson, T. J. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-571149-4.50011-8 · Cited by 32
Insulin resistance due to mutations of the insulin receptor gene: An overview
Accili, D., Cama, A., Barbetti, F., Kadowaki, H., Kadowaki, T., & Taylor, S. I. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348820 · Cited by 31
Tyrphostins inhibit the epidermal growth factor receptor‐mediated breakdown of phosphoinositides
Posner, I., Gazit, A., Gilon, C., & Levitzki, A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81554-6 · Cited by 26
Self-citationOkabe, T., Yoshida, E., Chieda, S., ENDO, K., Kamiya, S., OSADA, K., Tanaka, S., Okura, A., & Suda, H. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.289 · Cited by 15
Cited by
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Metadata
- Authors
- Levitzki, A., & Gazit, A.
- Venue
- Science
- Published
- 1995-03-24
- Volume
- 267
- Issue
- 5205
- Pages
- 1782-1788
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2058839845
- Cited by
- 1,635
- References
- 81
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.